BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: deLemos AS, Schmeltzer PA, Russo MW. Recurrent hepatitis C after liver transplant. World J Gastroenterol 2014; 20(31): 10668-10681 [PMID: 25152571 DOI: 10.3748/wjg.v20.i31.10668]
URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10668.htm
Number Citing Articles
1
Danielle Detelich, James F. Markmann. Normothermic liver preservation, current status and future directionsCurrent Opinion in Organ Transplantation 2018; 23(3): 347 doi: 10.1097/MOT.0000000000000531
2
Gary C. Kanel. Atlas of Liver Pathology2024; : 445 doi: 10.1016/B978-0-323-82533-7.00013-2
3
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2016; : 1 doi: 10.1007/978-3-319-05543-5_21-1
4
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2017; : 355 doi: 10.1007/978-3-319-07209-8_21
5
Wei Jiang, John L. Farber. Contemporary Liver Transplantation2016; : 1 doi: 10.1007/978-3-319-05543-5_21-2
6
Anne M. Larson, George B. McDonald. Transplant Infections2016; : 653 doi: 10.1007/978-3-319-28797-3_36
7
H. Imai, H. Kamei, Y. Onishi, Y. Ishizu, M. Ishigami, H. Goto, Y. Ogura. Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C VirusTransplantation Proceedings 2018; 50(5): 1431 doi: 10.1016/j.transproceed.2018.03.005
8
Marcos Mucenic, Ajacio Bandeira de Melo Brandão, Claudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Maria Lucia Zanotelli, Ian Leipnitz, Mário Henrique Meine, Guillermo Kiss, Juliano Martini, Eduardo Soares Schlindwein, Ane Micheli Costabeber, Fernanda Karlinsky Rodrigues Sacco, Giovana Rossato, Guido Pio Cracco Cantisani. Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and reviewRevista do Instituto de Medicina Tropical de São Paulo 2019; 61 doi: 10.1590/s1678-9946201961012
9
Dina M. Ahmed, Mona R. Abd-Alaziz, Ibrahim M. Ibrahim, Naglaa A. El-gendy. Retrospective study of the outcome of liver transplantation in Egyptian patients with chronic hepatitis C virus infectionThe Scientific Journal of Al-Azhar Medical Faculty, Girls 2020; 4(4): 631 doi: 10.4103/sjamf.sjamf_84_20
10
M. Mucenic, A. Bandeira de Mello Brandao, C.A. Marroni, A. Medeiros Fleck, M.L. Zanotelli, G. Kiss, M.H. Meine, I. Leipnitz, E. Soares Schlindwein, J. Martini, A.M. Costabeber, F.K.F. Sacco, G.P. Cracco Cantisani. Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World StudyTransplantation Proceedings 2018; 50(3): 769 doi: 10.1016/j.transproceed.2018.02.001
11
Alice C. Huang, Angela Beadles, Danielle Romero, William Berquist, Rachel Bensen, Paul Kwo, Rebecca B. Mckenzie. Sustained Virologic Remission in an 8‐Month‐old Pediatric Patient With Carbamoyl Phosphate Synthetase I Deficiency and Hepatitis C Infection Using Direct‐acting Antivirals Prior to Liver TransplantJournal of Pediatric Gastroenterology and Nutrition 2021; 72(3) doi: 10.1097/MPG.0000000000002856
12
Non-Neoplastic Diseases of the Liver2022; : 353 doi: 10.55418/9781933477183-11
13
M. Bodro, G. Sanclemente, G. Crespo, L. Linares, M.A. Marcos, F. Marco, R. Miquel, X. Forns, M. Navasa, A. Moreno. Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant RecipientsTransplantation Proceedings 2018; 50(5): 1437 doi: 10.1016/j.transproceed.2018.02.081